Hyperhomocysteinemia and metabolic syndrome are risk factors for sub-clinical atherosclerosis in women with systemic lupus erythematosus Serum BLyS and APRIL as possible indicators of disease activity in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis Interleukin-18 Gene Polymorphisms in Systemic Lupus Erythematosus: Relation to Disease Status Clinical significance of soluble programmed death-1(sPD-1) in rheumatoid arthritis patients: Relation to disease activity and functional status Serum and Synovial Granulocyte Colony Stimulating Factor (G-CSF) levels as markers of disease activity and severity in Rheumatoid Arthritis Clinical significance of soluble programmed death-1(sPD-1) in rheumatoid arthritis patients: Relation to disease activity and functional status Peroxisome proliferator-activated receptor gamma 5 expression in monocytes from rheumatoid arthritis 6 patients Diagnostic Value of Anti-Mutated Citrullinated Vimentin versus Anti- Keratin Anti-bodies In early Diagnosis of Rheumatoid Arthritis Serum and synovial survivin in rheumatoid arthritis: Relation to disease activity and severity Assessment of Endocan Serum Level in Patients with Behçet Disease: Relation to Disease Activity and Carotid Intima Media Thickness Serum Cystatin C and βeta2 Microglobulin as potential biomarkers in children with lupus nephritis Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level Hypovitaminosis D in patients with Ankylosing Spondylitis: Frequency and Consequences Interleukin -37 as an anti-1 inflammatory cytokine: Does its relation to disease activity suggest its 2 potential role in rheumatoid arthritis therapy?